NASDAQ:GLSI

Greenwich LifeSciences News Headlines

$35.90
+1.81 (+5.31 %)
(As of 05/5/2021 12:00 AM ET)
Add
Compare
Today's Range
$34.12
$36.32
50-Day Range
$28.70
$53.60
52-Week Range
$3.26
$158.07
Volume127,753 shs
Average Volume563,938 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Headlines

Greenwich LifeSciences (NASDAQ GLSI) News Headlines Today

SourceHeadline
Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Short Interest UpdateGreenwich LifeSciences, Inc. (NASDAQ:GLSI) Short Interest Update
americanbankingnews.com - April 30 at 1:42 PM
1 Drug, 1 Mission: What Should Investors Expect for Greenwich Life Sciences?1 Drug, 1 Mission: What Should Investors Expect for Greenwich Life Sciences?
finance.yahoo.com - April 21 at 2:26 PM
Greenwich LifeSciences Hires Industry Expert Dr. Christine Fischette to Lead Business Development & Advise on CommercializationGreenwich LifeSciences Hires Industry Expert Dr. Christine Fischette to Lead Business Development & Advise on Commercialization
finance.yahoo.com - April 19 at 12:55 PM
Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Short Interest Down 21.3% in MarchGreenwich LifeSciences, Inc. (NASDAQ:GLSI) Short Interest Down 21.3% in March
americanbankingnews.com - April 18 at 9:18 AM
The CEO, CFO & Director of Greenwich LifeSciences, Inc. (NASDAQ:GLSI), Snehal Patel, Just Bought A Few More SharesThe CEO, CFO & Director of Greenwich LifeSciences, Inc. (NASDAQ:GLSI), Snehal Patel, Just Bought A Few More Shares
nasdaq.com - April 16 at 9:17 AM
Trade Alert: The CEO, CFO & Director Of Greenwich LifeSciences, Inc. (NASDAQ:GLSI), Snehal Patel, Has Just Spent US$100k Buying A Few More SharesTrade Alert: The CEO, CFO & Director Of Greenwich LifeSciences, Inc. (NASDAQ:GLSI), Snehal Patel, Has Just Spent US$100k Buying A Few More Shares
finance.yahoo.com - April 16 at 9:17 AM
Why Insiders Are Trading Greenwich Lifesciences StockWhy Insiders Are Trading Greenwich Lifesciences Stock
insidertrades.com - April 15 at 11:35 AM
Stock Alert: Greenwich LifeSciences Up 7%Stock Alert: Greenwich LifeSciences Up 7%
nasdaq.com - April 14 at 3:32 PM
Greenwich LifeSciences Announces Update of GP2 Phase III Clinical Trial Design at the 2021 AACR Annual MeetingGreenwich LifeSciences Announces Update of GP2 Phase III Clinical Trial Design at the 2021 AACR Annual Meeting
finance.yahoo.com - April 14 at 10:32 AM
Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Buys $99,846.00 in StockGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Buys $99,846.00 in Stock
americanbankingnews.com - April 14 at 8:04 AM
REPEAT/Greenwich LifeSciences Presents Phase IIb Poster, Published April 10th at 2021 AACR Annual Meeting, Showing GP2 Immune Response Peaked at 6 Months, Resulting in 100% ...REPEAT/Greenwich LifeSciences Presents Phase IIb Poster, Published April 10th at 2021 AACR Annual Meeting, Showing GP2 Immune Response Peaked at 6 Months, Resulting in 100% ...
businesswire.com - April 12 at 8:40 AM
REPEAT/Greenwich LifeSciences Presents Phase IIb Poster, Published April 10th at 2021 AACR Annual Meeting, Showing GP2 Immune Response Peaked at 6 Months, Resulting in 100% Disease Free Survival from Recurring Breast CancerREPEAT/Greenwich LifeSciences Presents Phase IIb Poster, Published April 10th at 2021 AACR Annual Meeting, Showing GP2 Immune Response Peaked at 6 Months, Resulting in 100% Disease Free Survival from Recurring Breast Cancer
finance.yahoo.com - April 12 at 8:40 AM
Greenwich LifeSciences Presents Immune Response Phase IIb Poster, Published Today at AACR 2021, Showing Peak Immunity after 6 Months of GP2 Treatment, Resulting in 100% Disease ...Greenwich LifeSciences Presents Immune Response Phase IIb Poster, Published Today at AACR 2021, Showing Peak Immunity after 6 Months of GP2 Treatment, Resulting in 100% Disease ...
businesswire.com - April 11 at 8:09 AM
Greenwich LifeSciences Presents Immune Response Phase IIb Poster, Published Today at AACR 2021, Showing Peak Immunity after 6 Months of GP2 Treatment, Resulting in 100% Disease Free Survival from Recurring Breast CancerGreenwich LifeSciences Presents Immune Response Phase IIb Poster, Published Today at AACR 2021, Showing Peak Immunity after 6 Months of GP2 Treatment, Resulting in 100% Disease Free Survival from Recurring Breast Cancer
finance.yahoo.com - April 10 at 7:18 PM
Stock Alert: Greenwich LifeSciences Gains 6%Stock Alert: Greenwich LifeSciences Gains 6%
nasdaq.com - April 9 at 1:03 PM
Whats Going On With GLSI Stock And PSMT Stock Today?What's Going On With GLSI Stock And PSMT Stock Today?
benzinga.com - April 9 at 1:03 PM
Greenwich LifeSciences Stock Is Trading Higher After Breast Cancer Immunotherapy Shows 0% Recurrences Over 5 Years Follow-upGreenwich LifeSciences' Stock Is Trading Higher After Breast Cancer Immunotherapy Shows 0% Recurrences Over 5 Years Follow-up
finance.yahoo.com - April 9 at 1:03 PM
Why Greenwich LifeSciences Stock Is Rising TodayWhy Greenwich LifeSciences Stock Is Rising Today
finance.yahoo.com - April 9 at 1:03 PM
Greenwich LifeSciences Reports Robust Immune Response Phase IIb Data Supporting GP2 Clinical Outcome of 0% Metastatic Breast Cancer Recurrences Over 5 Years of Follow-upGreenwich LifeSciences Reports Robust Immune Response Phase IIb Data Supporting GP2 Clinical Outcome of 0% Metastatic Breast Cancer Recurrences Over 5 Years of Follow-up
finance.yahoo.com - April 9 at 8:03 AM
Read This Before Selling Greenwich LifeSciences, Inc. (NASDAQ:GLSI) SharesRead This Before Selling Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Shares
finance.yahoo.com - March 25 at 1:20 PM
Greenwich LifeSciences CEO to Participate on Cancer Panel and to Present at Benzinga Biotech ConferenceGreenwich LifeSciences CEO to Participate on Cancer Panel and to Present at Benzinga Biotech Conference
finance.yahoo.com - March 23 at 8:56 AM
Greenwich LifeSciences Could See Another Spike in Stock in Early AprilGreenwich LifeSciences Could See Another Spike in Stock in Early April
markets.businessinsider.com - March 22 at 12:54 PM
Exclusive: Greenwich LifeSciences CEO Calls Stocks Meteoric Rise Very EmotionalExclusive: Greenwich LifeSciences CEO Calls Stock's Meteoric Rise 'Very Emotional'
benzinga.com - March 11 at 6:01 PM
Greenwich LifeSciences Updates 2021 Timeline & Announces Two Upcoming Presentations at the American Association for Cancer Research Annual MeetingGreenwich LifeSciences Updates 2021 Timeline & Announces Two Upcoming Presentations at the American Association for Cancer Research Annual Meeting
finance.yahoo.com - March 11 at 8:00 AM
Greenwich LifeSciences CEO to be Interviewed Live on Benzinga’s Power HourGreenwich LifeSciences CEO to be Interviewed Live on Benzinga’s Power Hour
finance.yahoo.com - March 10 at 8:15 PM
Greenwich LifeSciences Hires Industry Expert, Dr. Jaye Thompson, to Manage Phase III Clinical Trial for Recurring Breast CancerGreenwich LifeSciences Hires Industry Expert, Dr. Jaye Thompson, to Manage Phase III Clinical Trial for Recurring Breast Cancer
finance.yahoo.com - March 8 at 9:08 AM
Greenwich LifeSciences to Present at Multiple Investor Conferences, Including H.C. Wainwright Global Life Sciences and BIO-Europe Spring ConferencesGreenwich LifeSciences to Present at Multiple Investor Conferences, Including H.C. Wainwright Global Life Sciences and BIO-Europe Spring Conferences
finance.yahoo.com - March 2 at 7:11 AM
Greenwich LifeSciences Announces Acceptance of Two Abstracts at Upcoming Major Cancer ConferenceGreenwich LifeSciences Announces Acceptance of Two Abstracts at Upcoming Major Cancer Conference
finance.yahoo.com - February 25 at 7:04 AM
Greenwich LifeSciences, Inc.: Greenwich LifeSciences CEO Interview to Air on Bloomberg International on the RedChip Money ReportGreenwich LifeSciences, Inc.: Greenwich LifeSciences CEO Interview to Air on Bloomberg International on the RedChip Money Report
finanznachrichten.de - January 31 at 12:52 AM
Greenwich LifeSciences Announces Exercise and Closing of Underwriter’s Over-Allotment OptionGreenwich LifeSciences Announces Exercise and Closing of Underwriter’s Over-Allotment Option
finance.yahoo.com - January 29 at 1:18 PM
Greenwich LifeSciences CEO Interview to Air on Bloomberg International on the RedChip Money ReportGreenwich LifeSciences CEO Interview to Air on Bloomberg International on the RedChip Money Report
finance.yahoo.com - January 29 at 8:18 AM
Greenwich LifeSciences, Inc.Greenwich LifeSciences, Inc.
fool.com - January 21 at 7:23 PM
Greenwich LifeSciences to Present at B. Riley Securities and BIO CEO & Investor ConferencesGreenwich LifeSciences to Present at B. Riley Securities and BIO CEO & Investor Conferences
finance.yahoo.com - January 21 at 8:37 AM
Greenwich LifeSciences Inc.Greenwich LifeSciences Inc.
barrons.com - January 13 at 4:37 AM
Greenwich LifeSciences to Participate in Multiple Virtual Investor Conferences During 2021 JP Morgan Healthcare WeekGreenwich LifeSciences to Participate in Multiple Virtual Investor Conferences During 2021 JP Morgan Healthcare Week
finance.yahoo.com - January 8 at 8:45 AM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Greenwich LifeSciences, Inc.- GLSISHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Greenwich LifeSciences, Inc.- GLSI
finance.yahoo.com - January 5 at 1:22 PM
Greenwich LifeSciences LD Micro Presentation Replay Now AvailableGreenwich LifeSciences' LD Micro Presentation Replay Now Available
benzinga.com - January 5 at 8:21 AM
Greenwich LifeSciences’ LD Micro Presentation Replay Now AvailableGreenwich LifeSciences’ LD Micro Presentation Replay Now Available
finance.yahoo.com - January 5 at 8:21 AM
Greenwich LifeSciences, Inc. Rings the Nasdaq Stock Market Opening Bell in Celebration of its IPOGreenwich LifeSciences, Inc. Rings the Nasdaq Stock Market Opening Bell in Celebration of its IPO
nasdaq.com - December 29 at 7:33 AM
Greenwich LifeSciences, Inc. Rings the Opening Bell in Celebration of its IPOGreenwich LifeSciences, Inc. Rings the Opening Bell in Celebration of its IPO
nasdaq.com - December 28 at 2:32 PM
Do Institutions Own Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Shares?Do Institutions Own Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Shares?
finance.yahoo.com - December 25 at 12:30 PM
Greenwich LifeSciences to Ring Nasdaq Opening Bell on December 28Greenwich LifeSciences to Ring Nasdaq Opening Bell on December 28
finance.yahoo.com - December 24 at 8:27 AM
Greenwich LifeSciences, Inc. Announces Closing of Public Offering of Common StockGreenwich LifeSciences, Inc. Announces Closing of Public Offering of Common Stock
finance.yahoo.com - December 22 at 12:18 PM
Stock Alert: Greenwich LifeSciences Shares Down 10%Stock Alert: Greenwich LifeSciences Shares Down 10%
markets.businessinsider.com - December 18 at 3:17 PM
Why Greenwich LifeSciences Stock Is Plunging TodayWhy Greenwich LifeSciences Stock Is Plunging Today
finance.yahoo.com - December 18 at 3:17 PM
Greenwich LifeSciences, Inc. Prices $26.4 Million Upsized Public Offering of Common StockGreenwich LifeSciences, Inc. Prices $26.4 Million Upsized Public Offering of Common Stock
finance.yahoo.com - December 18 at 8:46 AM
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Greenwich LifeSciences, Inc.- GLSISHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Greenwich LifeSciences, Inc.- GLSI
finance.yahoo.com - December 16 at 6:01 PM
Greenwich LifeSciences Announces Option Agreement for Pre-clinical Coronavirus Vaccine CandidatesGreenwich LifeSciences Announces Option Agreement for Pre-clinical Coronavirus Vaccine Candidates
finance.yahoo.com - December 15 at 6:58 AM
Stock Alert: Greenwich Life Sciences Down 20%Stock Alert: Greenwich Life Sciences Down 20%
nasdaq.com - December 14 at 2:40 PM
Greenwich LifeSciences Announces Poster Presentation on Its GP2 Phase III Clinical Trial Design for Recurring Breast CancerGreenwich LifeSciences Announces Poster Presentation on Its GP2 Phase III Clinical Trial Design for Recurring Breast Cancer
marketwatch.com - December 11 at 7:32 PM
This page was last updated on 5/6/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.